73
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Awareness of Abdominal Adiposity as a Cardiometabolic Risk Factor (The 5A Study): Mexico

, , , , &
Pages 107-117 | Published online: 28 Mar 2011

References

  • Villalpando S Shamah-Levy T Rojas R Aguilar-Salinas CA Trends for Type 2 diabetes and other cardiovascular risk factors in Mexico from 1993–2006 Salud Pública Méx 2010 52 Suppl 1 S72 S79
  • World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications Part 1: diagnosis and classification of diabetes mellitus Geneva, Switzerland Department of Noncommunicable Disease Surveillance 1999
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 2001 285 19 2486 2497 11368702
  • Alberti KG Eckel RH Grundy SM Harmonizing the metabolic syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute, American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 2009 120 16 1640 1645 19805654
  • Després JP Lemieux I Bergeron J Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk Arteroscler Thromb Vasc Biol 2008 28 6 1039 1049
  • Deurenberg P Yap M van Staveren WA Body mass index and percent body fat: a meta analysis among different ethnic groups Int J Obes Relat Metab Disord 1998 22 12 1164 1171 9877251
  • Deurenberg P Yap M Deurenberg P Is a re-evaluation of WHO body mass index cut-off values needed? The case of Asian in Singapore Nutr Rev 2003 61 5 Pt 2 S80 S87 12828197
  • Yusuf S Hawken S Ounpuu S Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study Lancet 2004 364 9438 937 952 15364185
  • Sanchez-Castillo CP Velazquez-Monroy O Berber A Anthropometric cutoff points for predicting chronic diseases in the Mexican National Health Survey 2000 Obes Res 2003 11 3 442 451 12634443
  • Grundy SM Cleeman JI Daniels SR Diagnosis and management of the metabolic syndrome: and American Heart Association/National Heart, Lung and Blood Institute Scientific Statement Circulation 2005 112 17 2735 2752 16157765
  • Després JP Lemieux I Prud’homme D Treatment of obesity: need to focus on high risk abdominally obese patients BMJ 2001 322 7288 716 720 11264213
  • American Diabetes Association Diagnosis criteria for diabetes mellitus. Diagnosis and classification of diabetes mellitus Diabetes Care 2010 33 Suppl 1 S62 S69 20042775
  • Barquera S Campos-Nonato I Hernández-Barrera L Obesidad y adiposidad central en adultos mexicanos: resultados de la Encuesta Nacional de Salud y Nutrición 2006 Salud Publica Mex 2009 51 Suppl 4 S595 S603 20464235
  • Karelis AD Brochu M Rabasa-Lhoret R Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 2004 30 5 569 572 15671927
  • Bodenheimer T Wagner E Grumbach K Improving primary care for patients with chronic illness JAMA 2002 288 14 1775 1779 12365965
  • Lau D Douketis JD Morrison K Hramiak I Sharma A Ur E for members of the Obesity Canada Clinical Practice Guidelines Expert Panel 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary] CMAJ 2007 176 8 Suppl S1 S13 17420481
  • World Health Organization Preventing chronic diseases: WHO global report First edition Geneva, Switzerland 2005
  • Córdova-Villalobos JA Barriguete-Meléndez JA Lara-Esqueda A Chronic non-communicable diseases in Mexico: epidemiologic synopsis and integral prevention Salud Publica Mex 2008 50 5 419 427 18852939
  • Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomized placebo controlled trial Lancet 2002 360 9326 7 22 12114036
  • Heart Outcomes Prevention Evaluation Study Investigators Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy Lancet 2000 355 9232 253 259 10675071
  • The CDC Diabetes Cost-effectiveness Group Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol reduction for type 2 diabetes JAMA 2002 287 19 2542 2551 12020335
  • Pan American Health Organization Regional strategy and plan of action on an integrated approach to the prevention and control of chronic diseases, including diet, physical activity and health Washington, DC Pan American Health Organization 2006
  • Saydah S Fradkin J Cowie C Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes JAMA 2004 291 3 335 342 14734596
  • Williams J Wake M Hesketh K Maher E Waters E Health-related quality of life of overweight and obese children JAMA 2005 293 1 70 76 15632338
  • Ferrari P Friedenreich C Matthews CE The role of measurement error in estimating levels of physical activity Am J Epidemiol 2007 166 8 832 840 17670910